HCAT - Health Catalyst Non-GAAP EPS of -$0.03 beats by $0.07 revenue of $70.63M beats by $0.75M
- Health Catalyst press release ( NASDAQ: HCAT ): Q2 Non-GAAP EPS of -$0.03 beats by $0.07 .
- Revenue of $70.63M (+18.5% Y/Y) beats by $0.75M .
- Financial Outlook
- Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.
- For the third quarter of 2022, we expect:
- Total revenue between $65.3 million and $68.3 million vs $74.56M consensus.
- For the full year of 2022, we expect:
- Total revenue between $271.5 million and $275.5 million vs $290.98M consensus.
For further details see:
Health Catalyst Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $70.63M beats by $0.75M